Amantadine binding protein
A technology of fusion proteins and sequences, applied in the field of amantadine-binding proteins
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0060] We used novel protein design to create a homotrimeric protein conjugated to the small molecule drug amantadine. The X-ray structure closely matches the designed model, the neutron structure recapitulates the designed hydrogen-bonding network (data not shown), and solution NMR data show that amantadine binding induces local structural changes (data not shown). C 3 Small molecule binding at symmetric protein interfaces is an advance in computational protein design.
[0061] Despite the importance of trimers in pro-apoptotic and pro-inflammatory signaling cascades, no chemically induced trimer system has been developed. Thus, the design of small molecule-inducible trimers is a challenge for entirely new protein design with considerable practical relevance.
[0062] We set out to design trimeric proteins that bind small molecules with threefold symmetry on their axis of symmetry. We focus on C 3 The symmetrical compound amantadine because it is an FDA-approved drug with...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com